Skip to main content
Clinical Trials/ACTRN12621001239853
ACTRN12621001239853
Completed
Phase 3

Effectiveness of intravenous iron administered during the third trimester in Malawian women in the management of anaemia: a 4-year, multicentre, parallel-group, two-arm, open-label randomised controlled superiority trial

Training and Research Unit of Excellence (TRUE), Malawi0 sites590 target enrollmentSeptember 14, 2021

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Anaemia
Sponsor
Training and Research Unit of Excellence (TRUE), Malawi
Enrollment
590
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2021
End Date
May 15, 2024
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Training and Research Unit of Excellence (TRUE), Malawi

Eligibility Criteria

Inclusion Criteria

  • Confirmed singleton pregnancy in the third trimester (27\-35 weeks of gestation, dated by Last Menstrual Period)
  • Moderate to severe anaemia not requiring an immediate blood transfusion (Hb \<10 g/dl)
  • Negative malaria parasitaemia by mRDT
  • Currently afebrile with no evidence of septicaemia
  • Resident in the study catchment area of Zomba district (Malawi)
  • Able to deliver at health facilities within Zomba district (Malawi)
  • Written informed consent (including assent if \<18 years old)

Exclusion Criteria

  • Previous enrolment in REVAMP trial – ACTRN12618001268235\.
  • Actively participating in another intervention trial.
  • Known hypersensitivity to any of the study drugs.
  • Clinical symptoms of malaria or other infection (no fever, no focal symptoms of internal infection i.e. LRTI/ diarrhoea).
  • Any condition requiring hospitalisation in the next seven days or serious concomitant illness.
  • Known history of sickle cell or sickle\-haemoglobin C anaemia.
  • Clinically low haemoglobin level requiring a blood transfusion (usually Hb \<5g/dl).
  • Preeclampsia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer.Iron-deficiency in colorectal cancerMedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2019-003819-56-DKCentre for Surgical Science134
Recruiting
Not Applicable
Effect of intravenous iron supplementation on the level of hemoglobin in staged bilateral knee arthroplastyDiseases of the musculoskeletal system and connective tissue
KCT0008823Chonnam National University Hospital Hwasun Hospital120
Recruiting
Not Applicable
Effect of intravenous iron supplementation on the level of hemoglobin in revision hip and knee arthroplastyDiseases of the musculo-skeletal system and connective tissue
KCT0005832Chonnam National University Hospital Hwasun Hospital120
Not yet recruiting
Not Applicable
Intravenous single dose iron infusioHealth Condition 1: D509- Iron deficiency anemia, unspecified
CTRI/2021/05/033579DST Chandigarh
Not yet recruiting
Phase 2
IV iron infusion therapy in patients with persistent pai
ACTRN12622000412730Metro North Health Services Royal Brisbane and Women's Hospital160